Compare Novavax Inc (NVAX) vs Oxford Lane Capital Corp (OXLC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Novavax Inc vs Oxford Lane Capital Corp — how do they compare? Novavax Inc trades at $8.08 (market cap $1.30B), while Oxford Lane Capital Corp trades at $8.82 (market cap $866.15M). The key difference: Novavax Inc is the larger of the two by market cap, and Oxford Lane Capital Corp pays a 27.06% dividend while Novavax Inc pays none. Which is the better fit depends on your goals.
| NVAX | OXLC | |
|---|---|---|
Market Cap | $1.30B | $866.15M |
Sector | Health | Financials |
52-Week High | $11.19 | $19.90 |
52-Week Low | $6.22 | $8.15 |
Enterprise Value | $800.50M | — |
Dividend Yield | — | 27.06% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Novavax Inc
Novavax, Inc. is a clinical stage biotechnology company. The Company creates novel vaccines to address a broad range of infectious diseases worldwide using proprietary virus-like particle (VLP) technology.
Read more on NVAX →About Oxford Lane Capital Corp
Oxford Lane Capital Corp. is a non-diversified, closed-end management investment company. Its primary investment objective is to achieve high current income, with a secondary objective of capital appreciation. The company primarily invests in equity and junior debt tranches of collateralized loan obligations (CLOs), which are pools of corporate loans. OXLC is known for its high-yield distribution policy and provides investors with leveraged exposure to the CLO market.
Read more on OXLC →
